ClinicalTrials.gov record
Terminated Not applicable Interventional

A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors

ClinicalTrials.gov ID: NCT03172832

Public ClinicalTrials.gov record NCT03172832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Randomized Trial of Percutaneous Transhepatic Biliary Drainage vs. Endoscopic Retrograde Cholangiography for Decompression of Suspected Malignant Biliary Hilar Obstruction - the INTERCPT Trial

Study identification

NCT ID
NCT03172832
Recruitment status
Terminated
Study type
Interventional
Phase
Not applicable
Lead sponsor
Medical University of South Carolina
Other
Enrollment
13 participants

Conditions and interventions

Interventions

  • ERC Procedure
  • PTBD Procedure

Procedure

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 19, 2017
Primary completion
Apr 11, 2019
Completion
Apr 11, 2019
Last update posted
Mar 24, 2020

2017 – 2019

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
22
Facility City State ZIP Site status
University of Southern California Los Angeles California 90033
Cedars Sinai Medical Center Los Angeles California 90048
Yale University New Haven Connecticut 74085
Sibley Memorial Hospital Washington D.C. District of Columbia 20016
University of Florida Gainesville Florida 32608
University of Florida - Jacksonville Jacksonville Florida 32209
Borland-Groover Clinic Jacksonville Florida 32258
Emory University Atlanta Georgia 30322
Northwestern University Chicago Illinois 60611
Johns Hopkins University Baltimore Maryland 21287
Boston University Boston Massachusetts 02118
University of Michigan Ann Arbor Michigan 48109
Saint Louis University St Louis Missouri 63103
Washington University St Louis Missouri 63130
Dartmouth University Lebanon New Hampshire 02714
Stony Brook University Stony Brook New York 11790
Case Western Reserve University Cleveland Ohio 44106
Ohio State University Columbus Ohio 43210
Fox Chase Cancer Center Philadelphia Pennsylvania 19111
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Nashville Tennessee 49795
Methodist Hospital Dallas Dallas Texas 75203
University of Virginia Charlottesville Virginia 22908
Virginia Commonwealth University Richmond Virginia 23219
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03172832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 24, 2020 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03172832 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →